Know how the loss making Sharon Bio-Medicine is doing at the markets today
Advertisement
Advertisement
Advertisement
Loss making Sharon Bio-Medicine was locked up 20 percent for the second day as the company said it expected to add to sales to the The USFDA inspected and audited
As a consequence, the company is hoping to add active pharma ingredient sales to the US as well as other nations. The move prompted the stock to surge nearly 44 percent in two sessions.
Today, Sharon surged 4.25 rupees, or 20 percent, to 25.60 rupees on the
(Image credits: Indiatimes)
Advertisement
- Should you be worried about the potential side-effects of the Covishield vaccine?
- India T20 World Cup squad: KulCha back on menu, KL Rahul dropped
- Sales of homes priced over ₹4 crore rise 10% in Jan-Mar in top 7 cities: CBRE
- Gold prices fluctuate as geopolitical tensions ease; US Fed meeting, payroll data to affect prices this week
- Best beaches to visit in Goa in 2024